Cathie Wood's position in Veracyte is currently worth $153M. That's 1.02% of their equity portfolio (30th largest holding). The investor owns 4.12% of the outstanding Veracyte stock. The first Veracyte trade was made in Q4 2016. Since then Cathie Wood bought shares nineteen more times and sold shares on sixteen occasions. The stake costed the investor $80.5M, netting the investor a gain of 90% so far.